• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus

tetano

Editor, Senior Moderator
Virology. 2017 Jan 19;503:31-36. doi: 10.1016/j.virol.2017.01.006. [Epub ahead of print]
[h=1]A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.[/h] Kim SH[SUP]1[/SUP], Paldurai A[SUP]1[/SUP], Samal SK[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Avian influenza (AI) is an economically-important disease of poultry worldwide. The use of vaccines to control AI has increased because of frequent outbreaks of the disease in endemic countries. Newcastle disease virus (NDV) vectored vaccine has shown to be effective in protecting chickens against a highly pathogenic avian influenza virus (HPAIV) infection. However, preexisting antibodies to NDV vector might affect protective efficacy of the vaccine in the field. As an alternative strategy, we evaluated vaccine efficacy of a chimeric NDV vectored vaccine in which the ectodomains of F and HN proteins were replaced by those of avian paramyxovirus serotype-2. The chimeric NDV vector stably expressed the HA protein in vivo, did not cross-react with NDV, was attenuated to be used as a safe vaccine, and provided a partial protection of 1-day-old immunized chickens against HPAIV subtype H5N1challenge, indicating its potential use for early protection of chickens.
Copyright ? 2017 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Avian influenza virus; Chickens; Newcastle disease virus; Protection; Vaccine

PMID: 28110247 DOI: 10.1016/j.virol.2017.01.006
[PubMed - as supplied by publisher]
 
Back
Top Bottom